Search Within

Viswanath Reddy Belum

Formats
  1. Journal Article (25)
  2. Meeting Abstract (11)
  3. Book Section (2)
Groups
  1. Sloan Kettering Institute Postdocs (38)
  2. Department of Medicine (37)
  3. Dermatology (37)
  4. Dermatology Service (37)
  5. Division of Subspecialty Medicine (37)
  6. Survivorship Research (37)

More Groups

People
  1. Mario Lacouture (37)
  2. Kathryn Ciccolini (8)
  3. Shari Goldfarb (8)
  4. Klaus Busam (4)
  5. Andrea Cercek Hanjis (3)
  6. Jason Konner (3)

More People

Years
  1. 2019 (1)
  2. 2018 (2)
  3. 2017 (9)
  4. 2016 (6)
  5. 2015 (10)
  6. 2014 (4)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Journal of the American Academy of Dermatology (6)
  3. Annals of Oncology (2)
  4. British Journal of Dermatology (2)
  5. Journal of Investigative Dermatology (2)
  6. Supportive Care in Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. Mosby Elsevier (6)
  3. Springer (5)
  4. Elsevier Inc. (3)
  5. Wiley Blackwell (3)
  6. Blackwell Publishing (2)

More Publishers

Results (38)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dermatologic cancer pain syndromes
    Book Section

    Svigos, K.; Belum, V. R.; Lacouture, M. E.
    In Gulati, A.; Puttanniah, V.; Bruel, B. M.; Rosenberg, W. S.; Hung, J. C. (Eds.) Essentials of Interventional Cancer Pain Management (2019)

    Fulltext@MSK | Save
  • The microbial flora of clinically infected cutaneous metastases
    Meeting Abstract

    Virgen, C. A.; Belum, V. R.; Barker, C. A.; Lacouture, M. E.
    Journal of Investigative Dermatology (2018)

    Fulltext@MSK | Save
  • The microbial flora of taxane therapy–associated nail disease in cancer patients
    Journal Article

    Virgen, C. A.; Belum, V. R.; Kamboj, M.; Goldfarb, S. B.; Blinder, V. S.; Gucalp, A.; Lacouture, M. E.
    Journal of the American Academy of Dermatology (2018)

    Fulltext@MSK | Save
  • A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA)
    Meeting Abstract

    Berman, B.; Konner, J.; Belum, V. R.; Dion, H.; Ciccolini, K.; Kitts, S.; Ye, R.; Ravipaty, S.; Akmaev, V. R.; Sarangarajan, R.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis
    Journal Article

    Dai, J.; Belum, V. R.; Wu, S.; Sibaud, V.; Lacouture, M. E.
    Journal of the American Academy of Dermatology (2017)

    Fulltext@MSK | Save
  • Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: Clinicopathological findings
    Journal Article

    Sibaud, V.; Eid, C.; Belum, V. R.; Combemale, P.; Barres, B.; Lamant, L.; Mourey, L.; Gomez-Roca, C.; Estilo, C. L.; Motzer, R.; more...
    Journal of the European Academy of Dermatology and Venereology (2017)

    Fulltext@MSK | Save
  • The microbial flora of taxane therapy-associated nail disease in cancer patients
    Meeting Abstract

    Virgen, C. A.; Belum, V. R.; Kamboj, M.; Goldfarb, S. B.; Blinder, V. S.; Gucalp, A.; Lacouture, M. E.
    Journal of Investigative Dermatology (2017)

    Fulltext@MSK | Save
  • A prospective, randomized, double-blinded, split-face/chest study of prophylactic topical dapsone 5% gel versus moisturizer for the prevention of cetuximab-induced acneiform rash
    Journal Article

    Belum, V. R.; Marchetti, M. A.; Dusza, S. W.; Cercek, A.; Kemeny, N. E.; Lacouture, M. E.
    Journal of the American Academy of Dermatology (2017)

    Fulltext@MSK | Save
  • Anticancer therapy interruption and diagnostic concordance between referring clinicians and dermatologists at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Barrios, D.; Ciccolini, K.; Phillips, G.; Lucas, A. S.; Hsu, M.; Freites-Martinez, A.; Deng, L.; Belum, R.; Lacouture, M.
    Journal of the American Academy of Dermatology (2017)

    Fulltext@MSK | Save
  • Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
    Journal Article

    Zarbo, A.; Belum, V. R.; Sibaud, V.; Oudard, S.; Postow, M. A.; Hsieh, J. J.; Motzer, R. J.; Busam, K. J.; Lacouture, M. E.
    British Journal of Dermatology (2017)

    Fulltext@MSK | Save